Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation

• Publication date

  2013-08-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.113.003042PMID 23979626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction in Inappropriate Therapy and Mortality through ICD Programming

  2013cited by this paper
• Shock efficacy of the subcutaneous ICD for prevention of sudden cardiac death: Initial multicenter experience

  2013cited by this paper
• Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT)

  2012cited by this paper
• Reduction in inappropriate therapy and mortality through ICD programming.

  2012cited by this paper
• Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study

  2012cited by this paper
• Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.

  2012cited by this paper
• Shock Efficacy of Subcutaneous Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death: Initial Multicenter Experience

  2012cited by this paper
• Clinical Predictors of Cardiovascular Implantable Electronic Device‐Related Infective Endocarditis

  2011cited by this paper
• Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions.

  2010cited by this paper
• Is Surface ECG a Useful Surrogate for Subcutaneous ECG?

  2010cited by this paper
• Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study

  2010cited by this paper
• An entirely subcutaneous implantable cardioverter-defibrillator.

  2010cited by this paper
• Guidelines for device-based therapy of cardiac rhythm abnormalities.

  2009cited by this paper
• Implantable cardioverter-defibrillator prescription in the elderly.

  2009cited by this paper
• Recent Trends in Utilization of Implantable Cardioverter‐Defibrillators in Survivors of Cardiac Arrest in the United States

  2009cited by this paper
• Prognostic importance of defibrillator shocks in patients with heart failure.

  2008cited by this paper
• Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

  2008cited by this paper
• Abstract 4659: Risk of Failure of Transvenous Implantable Cardioverter Defibrillator Leads

  2008cited by this paper
• ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker

  2008cited by this paper
• How to treat and identify device infections.

  2007cited by this paper
• Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years

  2007cited by this paper
• Electrical Storm in Patients with an Implanted Defibrillator: A Matter of Definition

  2007cited by this paper
• The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

  2006cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients

  2005cited by this paper
• Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients

  2004cited by this paper
• The usefulness of surface 12-lead electrocardiogram to predict intra-atrial conduction block after successful atrial flutter ablation.

  2003cited by this paper
• Analysis of electrocardiograms for subcutaneous monitors.

  2003cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators.

  1998cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.

  1997cited by this paper
• A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

  1997cited by this paper
• IMPROVED SURVIVAL WITH AN IMPLANTED DEFIBRILLATOR IN PATIENTS WITH CORONARY DISEASE AT HIGH RISK FOR VENTRICULAR ARRHYTHMIA

  1996cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

  1996cited by this paper
• Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

  1980cited by this paper
• Clinical Research

  year unknowncited by this paper

• Evaluation of subcutaneous implantable cardioverter defibrillator eligibility in ventricularly paced patients during rest and exercise: a prospective observational study.

  2026cites this paper
• The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices.

  2026cites this paper
• Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper.

  2026cites this paper
• Implantable Defibrillators: Which Is the Best Device for Each Patient?

  2025influential citation
• Contemporary Use of Non transvenous ICD.

  2025cites this paper
• The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice

  2025cites this paper
• Safety and performance of a novel defibrillation lead for left bundle branch area placement: primary results of the LEADR LBBAP clinical trial.

  2025cites this paper
• Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience

  2025cites this paper
• Inappropriate Shocks in Brugada Syndrome Patients With a Subcutaneous Implantable Cardioverter Defibrillator

  2025cites this paper
• Has the Time Come to Stop Performing Routine Defibrillation Testing for Subcutaneous Implantable Cardioverter Defibrillators?

  2025cites this paper
• Novel leadless atrial and ventricular pacing system with subcutaneous implantable cardiac defibrillator: A case of cross-platform device compatibility

  2025cites this paper
• Advancing Cardiac Care: A Narrative Review on the Promise of the Extravascular Implantable Cardioverter-Defibrillator

  2025cites this paper
• Long‐Term Follow‐Up of the S‐ICD: A 10‐Years Follow‐Up Study of a Large Single Center Cohort

  2025cites this paper
• Comparison of subcutaneous and transvenous implantable cardioverter-defibrillators: Insights from a single-center cohort in Taiwan.

  2025cites this paper
• What is the best pulse shape for pacing purposes?

  2025cites this paper
• The extravascular implantable cardioverter–defibrillator: technology, evidence, and clinical perspectives

  2025cites this paper
• A review of the extravascular implantable cardioverter-defibrillator system: technology, development, clinical outcomes, and global experience

  2025cites this paper
• Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: preliminary Enlighten study results and meta-analysis.

  2025cites this paper
• Totally Fluoroless Versus Limited Fluoroscopy-assisted Implantation: Identifying the Role of Fluoroscopy During Subcutaneous Implantable Cardioverter-defibrillator Implantation

  2025cites this paper
• Inappropriate shocks from subcutaneous and transvenous implantable cardioverter-defibrillators: Reports from the FDA MAUDE database.

  2025cites this paper
• Defibrillation Testing During Implantation of Subcutaneous Implantable Cardioverter Defibrillators.

  2025cites this paper
• ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.

  2025cites this paper
• Long-term outcomes of subcutaneous implantable cardioverter defibrillators: the French nationwide HONEST study.

  2025cites this paper
• Anatomical considerations for the nontransvenous implantable cardioverter-defibrillator implantation: A cadaver-based analysis

  2025cites this paper
• Why subcutaneous ICD does not record pause events?

  2024cites this paper
• Comparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a multicenter long-term retrospective follow-up

  2024cites this paper
• Do Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death in End-Stage Renal Disease Patients on Dialysis?

  2024cites this paper
• Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association

  2024cites this paper
• A rare case report of catecholaminergic polymorphic ventricular tachycardia with an uncommon CALM2 mutation

  2024cites this paper
• Preoperative Prediction of Shock Impedance for Subcutaneous Implantable Cardioverter Defibrillator Using Chest Computed Tomography.

  2024cites this paper
• Synthesized V7 QRS Amplitude and Oversensing Episodes in Patients With Subcutaneous Implantable Cardioverter‐Defibrillators

  2024cites this paper
• Subcutaneous versus transvenous implantable cardioverter defibrillator in hypertrophic cardiomyopathy: a systematic review and meta-analysis

  2024cites this paper
• Golf Swing-Induced Pacemaker Atrial Noise and Extraction: A Case Report and Literature Review

  2024cites this paper
• Cardiovascular Implantable Electronic Device Infections: A Contemporary Review.

  2024cites this paper
• Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population.

  2024cites this paper
• Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up

  2024influential citation
• Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study

  2024cites this paper
• Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial

  2024cites this paper
• Subcutaneous air entrapment after subcutaneous implantable cardioverter defibrillator implantation evaluated by computed tomography

  2024influential citation
• Personalized Screening Before Subcutaneous Cardioverter Defibrillator Implantation: Usefulness and Outcomes in Clinical Practice - The S-ICD Screening SIS Prospective Study.

  2024cites this paper
• Ten years of subcutaneous defibrillator therapy: Consolidated clinical evidence and future perspectives

  2024influential citation
• Validation of the PRAETORIAN Score in a large S-ICD collective - usefulness in clinical routine.

  2024cites this paper
• Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up.

  2024cites this paper
• Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?

  2024cites this paper
• Safety and Performance of the Subcutaneous Implantable Cardioverter Defibrillator Detection Algorithm INSIGHTTM in Pacemaker Patients

  2023cites this paper
• Intra-Abdominal Hemorrhage Triggering Inappropriate Therapy From a Subcutaneous Defibrillator

  2023cites this paper
• Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study

  2023cites this paper
• Humerus fracture during unsuccessful induction of ventricular fibrillation for subcutaneous implantable cardioverter-defibrillator testing

  2023cites this paper
• Two‐incision versus three‐incision implantation technique of subcutaneous implantable cardioverter defibrillator: Systematic review and meta‐analysis of 2076 patients

  2023cites this paper
• The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective

  2023cites this paper
• Superior vena cava obstruction and cardiovascular implantable electronic devices—a new era of leadless devices

  2023cites this paper
• Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a ‘heart team’ approach

  2023cites this paper
• Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case–control study

  2023cites this paper
• Acute Human Defibrillation Performance of a Subcutaneous Implantable Cardioverter-Defibrillator with an Additional Coil Electrode.

  2023cites this paper
• Impact of Age on Subcutaneous Implantable Cardioverter Defibrillator in a Large Patient Cohort: Mid-Term Follow-Up.

  2023cites this paper
• Assessing delivered pulse-energies by a nonlinear model

  2023cites this paper
• Long-Term Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator System.

  2023cites this paper
• Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report

  2023cites this paper
• Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.

  2023cites this paper
• Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator

  2023cites this paper
• Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator

  2023cites this paper
• Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.

  2023cites this paper
• How likely is the sense‐B‐noise to affect patients with subcutaneous implantable cardioverter‐defibrillators and can we solve that problem in every case?

  2023cites this paper
• Impact of Median Sternotomy on Safety and Efficacy of the Subcutaneous Implantable Cardioverter Defibrillator

  2023cites this paper
• Opportunities and drawbacks of the subcutaneous defibrillator across different clinical settings

  2023cites this paper
• Inappropriate Shocks With Subcutaneous Implantable Cardioverter-Defibrillator in a Young Patient: A Case Report

  2023cites this paper
• Systematic Review on S-ICD Lead Extraction

  2023cites this paper
• Ultrasound-Guided Pectoserratus Plane Block and Superficial Serratus Anterior Plane Block for Subcutaneous Implantable Cardioverter-Defibrillator Implantation: A Comparative Study

  2023cites this paper
• Substernal Extravascular Implantable Cardioverter-Defibrillator System Infections in Large Animals.

  2023cites this paper
• Clinical outcomes of subcutaneous implantable cardiac defibrillator implantation – Iran SICD registry

  2023cites this paper
• Inappropriate Shock Rates and Long-Term Complications due to Subcutaneous Implantable Cardioverter Defibrillators in Patients With and Without Heart Failure: Results From a Multicenter, International Registry.

  2023cites this paper
• The relationship between the incision line and position of the latissimus dorsi muscle for subcutaneous implantable cardioverter‐defibrillator intermuscular implantations

  2023cites this paper
• A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation

  2023cites this paper
• Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview

  2023influential citation
• Szubkután ICD-terápia

  2023cites this paper
• Clinical impact of ECG change on oversensing of subcutaneous implantable cardioverter-defibrillators.

  2022cites this paper
• Dynamic screening for S-ICD eligibility: one frame does not capture the whole story

  2022influential citation
• Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing

  2022cites this paper
• 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders.

  2022cites this paper
• Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making

  2022influential citation
• Subcutaneous and Transvenous ICDs: an Update on Contemporary Questions and Controversies

  2022cites this paper
• Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series

  2022cites this paper
• Long-term results of first-generation S-ICD systems: strong from the start and through the threats of time.

  2022cites this paper
• A real‐world experience of subcutaneous and transvenous implantable cardiac defibrillators—comparison with the PRAETORIAN study

  2022cites this paper
• Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS.

  2022cites this paper
• Can We Treat an Older Patient With a New Trick?

  2022cites this paper
• Current clinical practice of subcutaneous implantable cardioverter-defibrillator: Analysis using the JROAD-DPC database.

  2022cites this paper
• Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia

  2022cites this paper
• Propofol dose and efficacy of defibrillation testing during implantation of subcutaneous implantable cardioverter‐defibrillators: A retrospective, single center cohort study

  2022cites this paper
• Emerging Technologies in Electrophysiology: From Single-Chamber to Biventricular Leadless Pacemakers

  2022cites this paper
• Sense-B-noise: an enigmatic cause for inappropriate shocks in subcutaneous implantable cardioverter defibrillators

  2022influential citation
• Multicenter assessment of the outcomes of subcutaneous ICD implantation in patients with prior or future sternotomy

  2022cites this paper
• Development of a patient and clinician co-led education program to promote living well with an implantable cardioverter defibrillator: Insights from a pilot project

  2022influential citation
• The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice

  2022cites this paper
• Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy

  2022cites this paper
• The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication

  2022cites this paper
• Shockingly shiny shoes—Inappropriate discharge from a subcutaneous defibrillator

  2022cites this paper
• Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review

  2022cites this paper
• Bradycardia in Patients with Subcutaneous Implantable Defibrillators—An Overestimated Problem? Experience from a Large Tertiary Centre and a Review of the Literature

  2022cites this paper
• The subcutaneous implantable cardioverter-defibrillator should be reserved for niche indications

  2022cites this paper